Gasporox AB (GPX) AI Stock Analysis

• Market Cap: kr64.91M
• Dividend Yield: N/A
• Average Volume (3M): 5.49K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.18
• Revenue Growth: -15.54%
• EPS Growth: -263.54%
• Country: SE
• Employees: 20
• Sector: General
• Sector Strength: N/A
• Industry: Hardware, Equipment & Parts
• EPS (TTM): -0.03
• Shares Outstanding: 9,353,246
• 10 Day Avg. Volume: 3,959
• 30 Day Avg. Volume: 5,488
• PEG Ratio: -0.25
• Price to Book (P/B): 2.85
• Price to Sales (P/S): 2.23
• P/FCF Ratio: -21.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.95
• Revenue Forecast (FY): kr433.31M

• Rating: 46 Neutral
• Price Target: kr7.50 ▲(1.35% Upside)

The score is held back primarily by weak financial performance—TTM profitability worsened, operating cash flow turned negative, and leverage increased materially—raising execution and funding-risk concerns. Technicals are moderately supportive with improving short- to mid-term trend and positive MACD, but valuation remains challenged due to ongoing losses (negative P/E) and no dividend support.

Positive Factors

Multi-year revenue growth & high gross profit

Sustained multi-year revenue expansion and persistently high gross profit indicate clear product-market fit and scalable unit economics. Over 2–6 months this supports potential operating leverage if sales recover, giving the company a durable base to convert top-line strength into earnings with disciplined cost control.

Specialized non-invasive gas sensing product

A focused, technically differentiated product for packaged-food quality control addresses structural industry needs—food safety, waste reduction and shelf-life extension. This domain-specific IP and application focus provide long-lived demand drivers and defensibility versus generalist sensor vendors.

B2B sales model with service contracts & partnerships

A B2B model combining product sales, service contracts and integration partnerships creates recurring revenue potential and deeper customer ties. Over several months this can stabilize cash flows, raise switching costs, and accelerate adoption via partners embedding the tech into packaging supply chains.

Negative Factors

Sharp profitability deterioration (TTM losses)

A steep drop to ~-35% net margin in the TTM period signals the company is failing to convert gross profit into positive operating results. This structural profitability weakness raises the risk that losses will persist absent sustained revenue recovery or significant cost restructuring, eroding long-term equity value.

Negative operating cash flow (TTM)

A shift to negative operating cash flow increases cash burn and reliance on external financing. Over the next 2–6 months this constrains the firm's ability to fund R&D, customer deployments, and working capital organically, heightening execution and funding risk during a critical scaling phase.

Material increase in leverage

Debt growing to ~75% of equity materially reduces financial flexibility. With ongoing operating losses, higher leverage amplifies refinancing and covenant risks, may force dilutive equity raises or cost-cutting, and limits strategic investments needed to capture market opportunities over the medium term.

Gasporox AB Business Overview & Revenue Model

Company Description

Gasporox AB (publ) develops and commercializes products based on laser spectroscopy. It offers GasSpect series of sensors for headspace analysis; LeakSpect series of sensors for detecting leaks of carbon dioxide from packages; MicroLab laboratory instruments for research and development of packages and materials; and GPX1500, a non-intrusive oxygen headspace gas analyzer. The company also provides measurement services for package and process evaluations. Gasporox AB (publ) was founded in 2005 and is based in Lund, Sweden.

How the Company Makes Money

Gasporox AB generates revenue primarily through the sales of its gas sensor products and analytical systems to businesses in the food packaging industry, as well as other sectors requiring gas measurement solutions. The company operates on a B2B model, where it sells its technology to manufacturers and retailers who seek to improve product quality and safety. Key revenue streams include direct product sales, service contracts for maintenance and support of their systems, and partnerships with packaging companies that integrate Gasporox's technology into their products. Additionally, GPX may benefit from research and development contracts or grants related to advancements in gas sensing technology. Strategic collaborations with industry leaders further enhance its market reach and revenue potential.

Gasporox AB Financial Statement Overview

Summary

Despite strong multi-year revenue growth and high gross profit, profitability deteriorated in the TTM period with a meaningful operating/net loss and a much worse net margin versus the latest annual year. Balance-sheet risk increased as total debt rose materially (to roughly three-quarters of equity), and operating cash flow turned negative in TTM, raising near-term funding and execution risk.

Income Statement

Revenue has grown strongly over the long term (from 2020 through 2024), but TTM (Trailing-Twelve-Months) revenue is lower than the latest annual period, suggesting recent softness. Profitability remains the core issue: TTM (Trailing-Twelve-Months) shows a meaningful operating and net loss (net margin roughly -35%), deteriorating from the 2024 annual loss (about -8% net margin). A positive is that gross profit remains high, but the company has not been able to translate that into operating leverage, and the step-down in TTM (Trailing-Twelve-Months) earnings is a notable near-term concern.

Balance Sheet

The balance sheet still shows positive equity and a moderate overall leverage profile historically, but risk has increased sharply in the most recent period. Total debt rose materially in TTM (Trailing-Twelve-Months) versus 2024, pushing debt to roughly three-quarters of equity, which reduces financial flexibility. Returns on equity are negative across periods, and the TTM (Trailing-Twelve-Months) loss implies continued pressure on the equity base if losses persist.

Cash Flow

Cash generation is mixed. Operating cash flow was positive in 2023 and 2024, but turned negative in TTM (Trailing-Twelve-Months), aligning with weaker profitability and indicating higher cash burn risk. Free cash flow improved to slightly positive in TTM (Trailing-Twelve-Months) after being negative in recent annual periods, but the improvement is not yet supported by consistently positive operating cash flow, making the cash profile less dependable.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	28.29M	34.10M	31.43M	21.45M	15.74M	12.45M
Gross Profit	18.42M	33.10M	30.69M	22.45M	16.26M	13.16M
EBITDA	-2.37M	-347.00K	946.00K	-3.25M	-4.69M	-3.82M
Net Income	-9.80M	-2.68M	-1.25M	-4.56M	-5.39M	-4.36M
Balance Sheet
Total Assets	46.68M	39.97M	43.52M	44.43M	37.37M	41.14M
Cash, Cash Equivalents and Short-Term Investments	10.49M	6.81M	10.62M	14.56M	14.27M	24.23M
Total Debt	14.27M	2.32M	8.73M	8.43M	0.00	0.00
Total Liabilities	27.82M	13.28M	20.33M	19.99M	8.74M	7.07M
Stockholders Equity	18.86M	26.69M	23.19M	24.44M	28.63M	34.07M
Cash Flow
Free Cash Flow	422.00K	-3.52M	-3.98M	-8.28M	-9.91M	-6.09M
Operating Cash Flow	-2.56M	4.36M	3.34M	-1.19M	-3.39M	-642.00K
Investing Cash Flow	-7.45M	-7.52M	-7.04M	-7.01M	-6.52M	-5.45M
Financing Cash Flow	12.08M	-648.00K	-240.00K	8.50M	-53.00K	18.00M

Gasporox AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 7.40
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:GPX, the sentiment is Negative. The current price of 7.4 is above the 20-day moving average (MA) of 7.22, above the 50-day MA of 7.10, and below the 200-day MA of 7.46, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 47.16 is Neutral, neither overbought nor oversold. The STOCH value of 23.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:GPX.

Gasporox AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
ACCON	54 Neutral	kr751.69M	-30.12	-9.00%	―	-1.32%	51.89%
GPX	46 Neutral	kr64.91M	-6.62	―	―	-15.54%	-263.54%
RO	44 Neutral	kr57.33M	-2.29	-26.75%	―	-0.73%	-136.62%
FING.B	43 Neutral	kr68.18M	-0.75	-37.93%	―	-82.93%	94.83%
INSP	42 Neutral	kr8.55M	-0.31	-93.13%	―	-0.75%	65.47%